5
Botulinum toxin; Pharmaceutical preparations, for use in the following fields: Treatment of tics; pharmaceutical preparations for the treatment of muscular dystrophy; Pharmaceutical preparations, for use in the following fields: Treatment of dystonia; Pharmaceutical preparations, for use in the following fields: Treatment of cerebral palsy; Pharmaceutical preparations for the treatment of hyperhidrosis; pharmaceutical preparations for the treatment of headaches; Pharmaceutical preparations, for use in the following fields: Treatment of tremors; Pharmaceutical preparations for treating sports injuries; Pharmaceutical preparations for treating neurodegenerative diseases; Pharmaceutical preparations for the treatment of neurological disorder; Pharmaceutical preparations, for use in the following fields: Treatment of autonomic imbalances; Pharmaceutical preparations for the treatment of wrinkles; Pharmaceuticals for the treatment of pain; pharmaceutical preparations for treatment of smooth muscle disease; None of the aforesaid pharmaceutical preparations for diagnostic analytical purposes, not for experimental purposes and not for laboratory and research purposes